New biomaterials derived from poly(lactic acids) : novel approaches to combine biodegradation, x-ray contrast and controlled local drug release

• Yujing Wang and Leo H. Koole. A non-toxic additive to introduce X-ray contrast into poly(lactic acid). Implications for transient medical implants such as bioresorbable coronary vascular scaffolds. Annual meeting of Society For Biomaterials, Apr 2013, Boston, USA. • Leo H. Koole, Daniel G. Molin and Yujing Wang. A Non-Toxic Additive to Introduce X-Ray Contrast into Poly(lactic acid)s. Annual Conference of European Society for Biomaterials, Aug 2014, Liverpood, UK. • Yujing Wang, Daniel G. Molin, Nynke M.S. van den Akker and Leo H. Koole. Synergetic effect observed during development of drug-eluting biodegradable microspheres for transarterial chemoembolization (TACE) of solid tumors. 3rd Symposium on Innovative Polymers for Controlled Delivery (SIPCD), Sep 2014, Suzhou, China.

[1]  L. Koole,et al.  Synergetic effect observed during development of drug-eluting biodegradable microspheres for transarterial chemoembolization (TACE) of solid tumors. , 2015, Journal of controlled release : official journal of the Controlled Release Society.

[2]  Shanyong Zhang,et al.  Synergistic growth inhibition by sorafenib and cisplatin in human osteosarcoma cells. , 2015, Oncology reports.

[3]  P. Serruys,et al.  Early (before 6 months), late (6-12 months) and very late (after 12 months) angiographic scaffold restenosis in the ABSORB Cohort B trial. , 2015, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[4]  L. Koole,et al.  Preparation and structure of drug-carrying biodegradable microspheres designed for transarterial chemoembolization therapy , 2015, Journal of biomaterials science. Polymer edition.

[5]  P. Serruys,et al.  A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trial , 2015, The Lancet.

[6]  C. Hamm,et al.  Current status of bioresorbable scaffolds in the treatment of coronary artery disease. , 2014, Journal of the American College of Cardiology.

[7]  P. Tchounwou,et al.  Cisplatin in cancer therapy: molecular mechanisms of action. , 2014, European journal of pharmacology.

[8]  P. Serruys,et al.  Cost-Effectiveness of Percutaneous Coronary Intervention With Drug-Eluting Stents Versus Bypass Surgery for Patients With 3-Vessel or Left Main Coronary Artery Disease: Final Results From the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) Trial , 2014, Circulation.

[9]  C. Ohmann,et al.  TACE plus sorafenib for the treatment of hepatocellular carcinoma: results of the multicenter, phase II SOCRATES trial , 2014, Cancer Chemotherapy and Pharmacology.

[10]  P. Bie,et al.  Transarterial Chemoembolization (TACE) plus Sorafenib Versus TACE for Intermediate or Advanced Stage Hepatocellular Carcinoma: A Meta-Analysis , 2014, PloS one.

[11]  D. Steinberg,et al.  Advances in stent technologies and their effect on clinical efficacy and safety , 2014, Medical devices.

[12]  Yoshinobu Onuma,et al.  Bioresorbable scaffolds: rationale, current status, challenges, and future. , 2014, European heart journal.

[13]  R. Whitbourn,et al.  Dynamics of vessel wall changes following the implantation of the absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study at 6, 12, 24 and 36 months. , 2014, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[14]  R. Waksman,et al.  Bioresorbable metal scaffold for cardiovascular application: current knowledge and future perspectives. , 2014, Cardiovascular revascularization medicine : including molecular interventions.

[15]  L. Koole,et al.  A Nontoxic Additive to Introduce X‐Ray Contrast into Poly(Lactic Acid). Implications for Transient Medical Implants Such as Bioresorbable Coronary Vascular Scaffolds , 2014, Advanced healthcare materials.

[16]  T. Harita,et al.  Decade of histological follow-up for a fully biodegradable poly-L-lactic acid coronary stent (Igaki-Tamai stent) in humans: are bioresorbable scaffolds the answer? , 2014, Circulation.

[17]  N. Chavez-Tapia,et al.  Clinical practice guidelines: Management of Hepatocellular Carcinoma , 2014 .

[18]  M. Price Coronary stenting : a companion to Topol's Textbook of interventional cardiology , 2014 .

[19]  Yoshinobu Onuma,et al.  Bioresorbable Drug-Eluting Magnesium-Alloy Scaffold for Treatment of Coronary Artery Disease , 2013, International journal of molecular sciences.

[20]  Y. Shin,et al.  Sorafenib alone versus sorafenib combined with transarterial chemoembolization for advanced-stage hepatocellular carcinoma: results of propensity score analyses. , 2013, Radiology.

[21]  D. Quail,et al.  Microenvironmental regulation of tumor progression and metastasis , 2014 .

[22]  M. Welker,et al.  Antiangiogenic treatment in hepatocellular carcinoma: the balance of efficacy and safety , 2013, Cancer management and research.

[23]  A. Colombo,et al.  Looking into the future with bioresorbable vascular scaffolds , 2013, Expert review of cardiovascular therapy.

[24]  O. Abdel-Rahman,et al.  Combination Trans Arterial Chemoembolization (TACE) Plus Sorafenib for the Management of Unresectable Hepatocellular Carcinoma: A Systematic Review of the Literature , 2013, Digestive Diseases and Sciences.

[25]  Lihui Weng,et al.  An in situ forming biodegradable hydrogel-based embolic agent for interventional therapies. , 2013, Acta biomaterialia.

[26]  V. Lam,et al.  Transarterial chemoembolization with irinotecan beads in the treatment of colorectal liver metastases: systematic review. , 2013, Journal of vascular and interventional radiology : JVIR.

[27]  Lihui Weng,et al.  In vitro and in vivo evaluation of biodegradable embolic microspheres with tunable anticancer drug release. , 2013, Acta biomaterialia.

[28]  N. Nitta,et al.  Evaluation of the embolic effect and degradability of gelatin microspheres and gelpart particles , 2013, Minimally invasive therapy & allied technologies : MITAT : official journal of the Society for Minimally Invasive Therapy.

[29]  P. Serruys,et al.  Coronary stents: historical development, current status and future directions. , 2013, British medical bulletin.

[30]  C. Boni,et al.  A phase II randomized dose escalation trial of sorafenib in patients with advanced hepatocellular carcinoma. , 2013, The oncologist.

[31]  G. Han,et al.  Sorafenib in combination with transarterial chemoembolization improves the survival of patients with unresectable hepatocellular carcinoma: A propensity score matching study , 2013, Journal of digestive diseases.

[32]  Raimund Erbel,et al.  Safety and performance of the drug-eluting absorbable metal scaffold (DREAMS) in patients with de-novo coronary lesions: 12 month results of the prospective, multicentre, first-in-man BIOSOLVE-I trial , 2013, The Lancet.

[33]  S. Maithel,et al.  Safety and efficacy of doxorubicin drug-eluting bead transarterial chemoembolization in patients with advanced hepatocellular carcinoma. , 2013, Journal of vascular and interventional radiology : JVIR.

[34]  J. Jamart,et al.  Doxorubicin-loaded drug-eluting beads (DC Bead®) for use in transarterial chemoembolization: A stability assessment , 2013, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

[35]  P. Serruys,et al.  Five-year follow-up of the ABSORB bioresorbable everolimus-eluting vascular scaffold system: multimodality imaging assessment. , 2013, EuroIntervention.

[36]  A. Kastrati,et al.  Clinical impact of extended dual antiplatelet therapy after percutaneous coronary interventions in the drug-eluting stent era: a meta-analysis of randomized trials. , 2012, European heart journal.

[37]  A. Sood,et al.  Resistance and escape from antiangiogenesis therapy: clinical implications and future strategies. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[38]  R. Whitbourn,et al.  Clinical and intravascular imaging outcomes at 1 and 2 years after implantation of absorb everolimus eluting bioresorbable vascular scaffolds in small vessels. Late lumen enlargement: does bioresorption matter with small vessel size? Insight from the ABSORB cohort B trial , 2012, Heart.

[39]  P. Serruys,et al.  TCT-37 Five-year Clinical Outcomes and Non-invasive Angiographic Imaging Results With Functional Assessment After Bioresorbable Everolimus-eluting Scaffold Implantation in Patients with De Novo Coronary Artery Disease , 2012 .

[40]  Wan Md Zin Wan Yunus,et al.  Mechanical, Thermal and Morphological Properties of Poly(lactic acid)/Epoxidized Palm Olein Blend , 2012, Molecules.

[41]  H. Hemker,et al.  Thrombin generation: what have we learned? , 2012, Blood reviews.

[42]  R. Lencioni Management of hepatocellular carcinoma with transarterial chemoembolization in the era of systemic targeted therapy. , 2012, Critical reviews in oncology/hematology.

[43]  S. Hori,et al.  Current status of embolic agents for liver tumor embolization , 2012, International Journal of Clinical Oncology.

[44]  G. Dangas,et al.  Late Stent Thrombosis: The Last Remaining Obstacle in Coronary Interventional Therapy , 2012, Current Cardiology Reports.

[45]  Patrick W Serruys,et al.  Everolimus-eluting ABSORB bioresorbable vascular scaffold: present and future perspectives , 2012, Expert review of medical devices.

[46]  Patrick W Serruys,et al.  The ABSORB bioresorbable vascular scaffold: an evolution or revolution in interventional cardiology? , 2012, Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese.

[47]  D. Steinberg,et al.  Everolimus-eluting stents in interventional cardiology , 2012, Vascular health and risk management.

[48]  W. S. Rasband,et al.  ImageJ: Image processing and analysis in Java , 2012 .

[49]  J. Bruix,et al.  Survival of patients with hepatocellular carcinoma treated by transarterial chemoembolisation (TACE) using Drug Eluting Beads. Implications for clinical practice and trial design. , 2012, Journal of hepatology.

[50]  R. Whitbourn,et al.  Vascular response of the segments adjacent to the proximal and distal edges of the ABSORB everolimus-eluting bioresorbable vascular scaffold: 6-month and 1-year follow-up assessment: a virtual histology intravascular ultrasound study from the first-in-man ABSORB cohort B trial. , 2012, JACC. Cardiovascular interventions.

[51]  P. Serruys,et al.  Stent Thrombosis With Everolimus-Eluting Stents: Meta-Analysis of Comparative Randomized Controlled Trials , 2012, Circulation. Cardiovascular interventions.

[52]  G. Carrafiello,et al.  Quality-Improvement Guidelines for Hepatic Transarterial Chemoembolization , 2012, CardioVascular and Interventional Radiology.

[53]  E. Alexopoulou,et al.  Chemoembolization With Doxorubicin-Eluting Beads for Unresectable Hepatocellular Carcinoma: Five-Year Survival Analysis , 2012, CardioVascular and Interventional Radiology.

[54]  A. Lloyd,et al.  Development of a combination drug-eluting bead: towards enhanced efficacy for locoregional tumour therapies , 2012, Anti-cancer drugs.

[55]  Patrycja Wojciechowska The Effect of Concentration and Type of Plasticizer on the Mechanical Properties of Cellulose Acetate Butyrate Organic-Inorganic Hybrids , 2012 .

[56]  V. Conteduca,et al.  Transarterial chemoembolization plus sorafenib: a sequential therapeutic scheme for HCV-related intermediate-stage hepatocellular carcinoma: a randomized clinical trial. , 2012, The oncologist.

[57]  C. Macaya,et al.  Absorbable stent: focus on clinical applications and benefits , 2012, Vascular health and risk management.

[58]  Xiabin Jing,et al.  Biodegradable synthetic polymers: Preparation, functionalization and biomedical application , 2012 .

[59]  David L. Woods,et al.  Radiopaque drug-eluting beads for transcatheter embolotherapy: experimental study of drug penetration and coverage in swine. , 2012, Journal of vascular and interventional radiology : JVIR.

[60]  Lin Xiao,et al.  Poly(Lactic Acid)-Based Biomaterials: Synthesis, Modification and Applications , 2012 .

[61]  I. Heschel,et al.  Vascular potency of Sus scrofa bone marrow-derived mesenchymal stem cells: a progenitor source of medial but not endothelial cells. , 2012, Tissue engineering. Part A.

[62]  R. Maciel Filho,et al.  Poly (Lactic Acid) Production for Tissue Engineering Applications , 2012 .

[63]  Patrick W Serruys,et al.  Four-year clinical follow-up of the ABSORB everolimus-eluting bioresorbable vascular scaffold in patients with de novo coronary artery disease: the ABSORB trial. , 2012, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[64]  Rubens Maciel Filho,et al.  Poly-lactic acid synthesis for application in biomedical devices - a review. , 2012, Biotechnology advances.

[65]  Robert C. G. Martin,et al.  Safety and efficacy of trans arterial chemoembolization with drug-eluting beads in hepatocellular cancer: a systematic review. , 2012, Hepato-gastroenterology.

[66]  Jian-hua Wang,et al.  The efficacy of TACE combined sorafenib in advanced stages hepatocellullar carcinoma , 2012, BMC Cancer.

[67]  R. Whitbourn,et al.  Serial in vivo intravascular ultrasound-based echogenicity changes of everolimus-eluting bioresorbable vascular scaffold during the first 12 months after implantation insights from the ABSORB B trial. , 2011, JACC. Cardiovascular interventions.

[68]  C. Bartolozzi,et al.  Conventional versus doxorubicin-eluting bead transarterial chemoembolization for hepatocellular carcinoma. , 2011, Journal of vascular and interventional radiology : JVIR.

[69]  T. Pawlik,et al.  Phase II trial of sorafenib combined with concurrent transarterial chemoembolization with drug-eluting beads for hepatocellular carcinoma. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[70]  M. Kudo,et al.  Phase III study of sorafenib after transarterial chemoembolisation in Japanese and Korean patients with unresectable hepatocellular carcinoma. , 2011, European journal of cancer.

[71]  Antonio Colombo,et al.  Comparison of coronary bypass surgery with drug-eluting stenting for the treatment of left main and/or three-vessel disease: 3-year follow-up of the SYNTAX trial. , 2011, European heart journal.

[72]  Anders Axelsson,et al.  The mechanisms of drug release in poly(lactic-co-glycolic acid)-based drug delivery systems--a review. , 2011, International journal of pharmaceutics.

[73]  Hongzhi Liu,et al.  Research progress in toughening modification of poly(lactic acid) , 2011 .

[74]  R. Sauro,et al.  Bare-Metal Stents Versus Drug-Eluting Stents for Primary Angioplasty: Long-Term Outcome , 2011, Current cardiology reports.

[75]  M. Welker,et al.  Anti-angiogenesis in hepatocellular carcinoma treatment: current evidence and future perspectives. , 2011, World journal of gastroenterology.

[76]  T. George,et al.  The combination of sorafenib with transarterial chemoembolisation for hepatocellular carcinoma , 2011, Alimentary pharmacology & therapeutics.

[77]  Cato T Laurencin,et al.  Biomedical Applications of Biodegradable Polymers. , 2011, Journal of polymer science. Part B, Polymer physics.

[78]  P. Serruys,et al.  Bioresorbable scaffold technologies. , 2011, Circulation journal : official journal of the Japanese Circulation Society.

[79]  Marisa Masumi Beppu,et al.  Natural-based plasticizers and biopolymer films: A review , 2011 .

[80]  P. Serruys,et al.  Developments in coronary artery stenting: primum non nocere. , 2011, Panminerva medica.

[81]  David M Martin,et al.  Drug-eluting stents for coronary artery disease: a review. , 2011, Medical engineering & physics.

[82]  Dietrich Büsselberg,et al.  Cisplatin as an Anti-Tumor Drug: Cellular Mechanisms of Activity, Drug Resistance and Induced Side Effects , 2011, Cancers.

[83]  F. H. van der Veen,et al.  Hydrophilic surface coatings with embedded biocidal silver nanoparticles and sodium heparin for central venous catheters. , 2011, Biomaterials.

[84]  Syam P Nukavarapu,et al.  Short-term and long-term effects of orthopedic biodegradable implants. , 2011, Journal of long-term effects of medical implants.

[85]  Q. Wei,et al.  Improving the blood compatibility of material surfaces via biomolecule-immobilized mussel-inspired coatings. , 2011, Journal of biomedical materials research. Part A.

[86]  Y. Dundar,et al.  Drug-eluting stents versus bare metal stents for angina or acute coronary syndromes. , 2015, The Cochrane database of systematic reviews.

[87]  J. Geschwind,et al.  Transcatheter Arterial Chemoembolization for Liver Cancer: Is It Time to Distinguish Conventional from Drug-Eluting Chemoembolization? , 2011, CardioVascular and Interventional Radiology.

[88]  J. Benoit,et al.  Local implantation of doxorubicin drug eluting beads in rat glioma. , 2010, International journal of pharmaceutics.

[89]  C. Mathers,et al.  Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.

[90]  R. P. John,et al.  An overview of the recent developments in polylactide (PLA) research. , 2010, Bioresource technology.

[91]  M. Shaver,et al.  Tacticity control in the synthesis of poly(lactic acid) polymer stars with dipentaerythritol cores. , 2010, Biomacromolecules.

[92]  P. Serruys,et al.  Three-year results of clinical follow-up after a bioresorbable everolimus-eluting scaffold in patients with de novo coronary artery disease: the ABSORB trial. , 2010, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[93]  Patrick W Serruys,et al.  Coronary stents: looking forward. , 2010, Journal of the American College of Cardiology.

[94]  P. Serruys,et al.  Coronary stents: current status. , 2010, Journal of the American College of Cardiology.

[95]  Steve Davies,et al.  ORIGINAL RESEARCH: The eco-profile for current Ingeo® polylactide production , 2010 .

[96]  David L. Woods,et al.  Development of "imageable" beads for transcatheter embolotherapy. , 2010, Journal of vascular and interventional radiology : JVIR.

[97]  R. Dhanasekaran,et al.  Comparison of conventional transarterial chemoembolization (TACE) and chemoembolization with doxorubicin drug eluting beads (DEB) for unresectable hepatocelluar carcinoma (HCC) , 2010, Journal of surgical oncology.

[98]  H. Bøtker,et al.  Efficacy and safety of zotarolimus-eluting and sirolimus-eluting coronary stents in routine clinical care (SORT OUT III): a randomised controlled superiority trial , 2010, The Lancet.

[99]  I. Krämer,et al.  Stability of irinotecan-loaded drug eluting beads (DC BeadTM) used for transarterial chemoembolization , 2010, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

[100]  Loes M. J. Kroon-Batenburg,et al.  EVAL15: a diffraction data integration method based on ab initio predicted profiles , 2010 .

[101]  U. Fiedler,et al.  The Potency of Refined Mouse Models: Implications for Clinical Trials , 2010 .

[102]  S. Rigby,et al.  The initial release of cisplatin from poly(lactide-co-glycolide) microspheres. , 2010, International journal of pharmaceutics.

[103]  D. Harnois,et al.  Aging of Hepatitis C Virus (HCV)-Infected Persons in the United States: A Multiple Cohort Model of HCV Prevalence and Disease Progression , 2010 .

[104]  M. Gandolfi,et al.  Evaluation of the radiopacity of calcium silicate cements containing different radiopacifiers. , 2010, International endodontic journal.

[105]  Anastasia Pomoni,et al.  Prospective Randomized Comparison of Chemoembolization with Doxorubicin-Eluting Beads and Bland Embolization with BeadBlock for Hepatocellular Carcinoma , 2010, CardioVascular and Interventional Radiology.

[106]  V. Çakır,et al.  Looking for the Ideal Particle: An Experimental Embolization Study , 2010, CardioVascular and Interventional Radiology.

[107]  R. Rapoza,et al.  Design principles and performance of bioresorbable polymeric vascular scaffolds. , 2009, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[108]  N. Nitta,et al.  Prolonged local persistence of cisplatin-loaded gelatin microspheres and their chemoembolic anti-cancer effect in rabbits. , 2009, European journal of radiology.

[109]  T. Vogl,et al.  Prospective Randomized Study of Doxorubicin-Eluting-Bead Embolization in the Treatment of Hepatocellular Carcinoma: Results of the PRECISION V Study , 2009, CardioVascular and Interventional Radiology.

[110]  Y. Levy,et al.  Evaluation of drug-eluting stents' coating durability--clinical and regulatory implications. , 2009, Journal of biomedical materials research. Part B, Applied biomaterials.

[111]  Sung W. Shin The Current Practice of Transarterial Chemoembolization for the Treatment of Hepatocellular Carcinoma , 2009, Korean journal of radiology.

[112]  B. Ashrafi,et al.  The influence of a compatibilizer on the thermal and dynamic mechanical properties of PEEK/carbon nanotube composites , 2009, Nanotechnology.

[113]  Peter Jüni,et al.  Correlation of Intravascular Ultrasound Findings With Histopathological Analysis of Thrombus Aspirates in Patients With Very Late Drug-Eluting Stent Thrombosis , 2009, Circulation.

[114]  Richard C. Thompson,et al.  Our plastic age , 2009, Philosophical Transactions of the Royal Society B: Biological Sciences.

[115]  R. Virmani,et al.  Comparison of Inflammatory Response After Implantation of Sirolimus- and Paclitaxel-Eluting Stents in Porcine Coronary Arteries , 2009, Circulation.

[116]  A. Lewis DC Bead™: a major development in the toolbox for the interventional oncologist , 2009, Expert review of medical devices.

[117]  C. Isella,et al.  The Thioxotriazole Copper(II) Complex A0 Induces Endoplasmic Reticulum Stress and Paraptotic Death in Human Cancer Cells* , 2009, The Journal of Biological Chemistry.

[118]  Bochu Wang,et al.  Biodegradation of Silk Biomaterials , 2009, International journal of molecular sciences.

[119]  Patrick W Serruys,et al.  A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods , 2009, The Lancet.

[120]  Anthony L. Spek,et al.  Structure validation in chemical crystallography , 2009, Acta crystallographica. Section D, Biological crystallography.

[121]  P. Serruys,et al.  Advances in stent drug delivery: the future is in bioabsorbable stents. , 2009, Expert Opinion on Drug Delivery.

[122]  S. Paggi,et al.  Sorafenib in Advanced Hepatocellular Carcinoma , 2008 .

[123]  P. Sasieni,et al.  Cancer mortality in the United Kingdom: projections to the year 2025 , 2008, British Journal of Cancer.

[124]  M. Mulcahy,et al.  Comparison of hypoxia-inducible factor-1alpha expression before and after transcatheter arterial embolization in rabbit VX2 liver tumors. , 2008, Journal of vascular and interventional radiology : JVIR.

[125]  Xiaoping Guo Radiopaque, barium sulfate‐filled biomedical compounds of a poly(ether‐block‐amide) copolymer , 2008 .

[126]  S. Vaidya,et al.  An Overview of Embolic Agents , 2008, Seminars in interventional radiology.

[127]  L. Lim,et al.  Processing technologies for poly(lactic acid) , 2008 .

[128]  Renu Virmani,et al.  Pathophysiology of vascular healing and stent mediated arterial injury. , 2008, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[129]  Mitchell W Krucoff,et al.  Postmarket evaluation of breakthrough technologies. , 2008, American heart journal.

[130]  R. Virmani,et al.  Endothelial cell recovery between comparator polymer-based drug-eluting stents. , 2008, Journal of the American College of Cardiology.

[131]  J. W. Hirshfeld Essentials of Restenosis for the Interventional Cardiologist , 2008 .

[132]  Bin Wang,et al.  Increased expression of vascular endothelial growth factor in hepatocellular carcinoma after transcatheter arterial chemoembolization , 2008, Acta radiologica.

[133]  C. Mario,et al.  Biodegradable drug-eluting stents: promises and pitfalls , 2008, The Lancet.

[134]  Patrick W Serruys,et al.  A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial , 2008, The Lancet.

[135]  Alain Bourmaud,et al.  Effect of thermo-mechanical cycles on the physico-chemical properties of poly(lactic acid) , 2008 .

[136]  Rob W. W. Hooft,et al.  Determination of absolute structure using Bayesian statistics on Bijvoet differences , 2008, Journal of applied crystallography.

[137]  P. Deluca,et al.  A model-dependent approach to correlate accelerated with real-time release from biodegradable microspheres , 2005, AAPS PharmSciTech.

[138]  G. Biondi-Zoccai,et al.  Safety of drug-coated stents. , 2008, Expert opinion on drug safety.

[139]  G. Sheldrick A short history of SHELX. , 2008, Acta crystallographica. Section A, Foundations of crystallography.

[140]  M. Huneault,et al.  Effect of nucleation and plasticization on the crystallization of poly(lactic acid) , 2007 .

[141]  Y. Inoue,et al.  Polymorphous Crystallization and Multiple Melting Behavior of Poly(l-lactide): Molecular Weight Dependence , 2007 .

[142]  Michael Joner,et al.  Vascular Responses to Drug Eluting Stents: Importance of Delayed Healing , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[143]  Raimund Erbel,et al.  Temporary scaffolding of coronary arteries with bioabsorbable magnesium stents: a prospective, non-randomised multicentre trial , 2007, The Lancet.

[144]  R. Virmani,et al.  Pathological Correlates of Late Drug-Eluting Stent Thrombosis: Strut Coverage as a Marker of Endothelialization , 2007, Circulation.

[145]  T. Paunesku,et al.  Effect of transcatheter arterial embolization on levels of hypoxia-inducible factor-1alpha in rabbit VX2 liver tumors. , 2007, Journal of vascular and interventional radiology : JVIR.

[146]  L. Koole,et al.  New acrylic microspheres for arterial embolization: combining radiopacity for precise localization with immobilized thrombin to trigger local blood coagulation. , 2007, Biomaterials.

[147]  Jeffrey W. Clark,et al.  Safety, pharmacokinetics, and preliminary antitumor activity of sorafenib: a review of four phase I trials in patients with advanced refractory solid tumors. , 2007, The oncologist.

[148]  P. Serruys,et al.  A pooled analysis of data comparing sirolimus-eluting stents with bare-metal stents. , 2007, The New England journal of medicine.

[149]  R. Reis,et al.  Water absorption and degradation characteristics of chitosan-based polyesters and hydroxyapatite composites. , 2007, Macromolecular bioscience.

[150]  J. Caridi,et al.  Renal artery embolization: application and success in patients with renal cell carcinoma and angiomyolipoma. , 2007, Seminars in interventional radiology.

[151]  L. Koole,et al.  Thrombus formation at the surface of guide-wire models: effects of heparin-releasing or heparin-exposing surface coatings. , 2007, Journal of vascular and interventional radiology : JVIR.

[152]  J. Bruix,et al.  Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics. , 2007, Journal of hepatology.

[153]  Michael Joner,et al.  Drug-Eluting Stent and Coronary Thrombosis: Biological Mechanisms and Clinical Implications , 2007, Circulation.

[154]  D. Gokhale,et al.  Lactic acid production from waste sugarcane bagasse derived cellulose , 2007 .

[155]  A. Lewis,et al.  Irinotecan drug eluting beads for use in chemoembolization: in vitro and in vivo evaluation of drug release properties. , 2007, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[156]  S. Wilhelm,et al.  Sorafenib (BAY 43-9006) inhibits tumor growth and vascularization and induces tumor apoptosis and hypoxia in RCC xenograft models , 2007, Cancer Chemotherapy and Pharmacology.

[157]  E. Cholongitas,et al.  Transarterial Therapy for Hepatocellular Carcinoma: Which Technique Is More Effective? A Systematic Review of Cohort and Randomized Studies , 2007, CardioVascular and Interventional Radiology.

[158]  S. Wilhelm,et al.  Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5. , 2006, Cancer research.

[159]  Xiaobo Liu,et al.  Kinetics of thermo-oxidative and thermal degradation of poly(d,l-lactide) (PDLLA) at processing temperature , 2006 .

[160]  Laura Marelli,et al.  Treatment outcomes for hepatocellular carcinoma using chemoembolization in combination with other therapies. , 2006, Cancer treatment reviews.

[161]  S. Wilhelm,et al.  Discovery and development of sorafenib: a multikinase inhibitor for treating cancer , 2006, Nature Reviews Drug Discovery.

[162]  Tzong‐Ming Wu,et al.  Biodegradable poly(lactic acid)/chitosan-modified montmorillonite nanocomposites: Preparation and characterization , 2006 .

[163]  A. Lewis,et al.  Pharmacokinetic and safety study of doxorubicin-eluting beads in a porcine model of hepatic arterial embolization. , 2006, Journal of vascular and interventional radiology : JVIR.

[164]  Hyun Jung Chung,et al.  Heparin Immobilized Porous PLGA Microspheres for Angiogenic Growth Factor Delivery , 2006, Pharmaceutical Research.

[165]  Sanjay Deshmukh,et al.  Studies Toward Producing Eco-Friendly Plastics , 2006 .

[166]  H. Chung,et al.  Biodegradable polymeric microspheres with "open/closed" pores for sustained release of human growth hormone. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[167]  P. Simamora,et al.  Poly-L-lactic acid: an overview. , 2006, Journal of drugs in dermatology : JDD.

[168]  A. Lloyd,et al.  DC bead: in vitro characterization of a drug-delivery device for transarterial chemoembolization. , 2006, Journal of vascular and interventional radiology : JVIR.

[169]  H. Hemker,et al.  Thrombin generation, a function test of the haemostaticthrombotic system , 2006, Thrombosis and Haemostasis.

[170]  R. Virmani,et al.  Differential Response of Delayed Healing and Persistent Inflammation at Sites of Overlapping Sirolimus- or Paclitaxel-Eluting Stents , 2005, Circulation.

[171]  Jianbo Ji,et al.  Studies on the poly(lactic-co-glycolic) acid microspheres of cisplatin for lung-targeting. , 2005, International journal of pharmaceutics.

[172]  Linbo Wu,et al.  In vitro degradation of three-dimensional porous poly(D,L-lactide-co-glycolide) scaffolds for tissue engineering. , 2004, Biomaterials.

[173]  Kenji Okamura,et al.  Tensile properties and biological response of poly(L-lactic acid) felt graft: an experimental trial for rotator-cuff reconstruction. , 2004, Journal of biomedical materials research. Part B, Applied biomaterials.

[174]  Douglas E. Hirt,et al.  Modification of poly(lactic acid) films: Enhanced wettability from surface-confined photografting and increased degradation rate due to an artifact of the photografting process , 2004 .

[175]  D. Auclair,et al.  BAY 43-9006 Exhibits Broad Spectrum Oral Antitumor Activity and Targets the RAF/MEK/ERK Pathway and Receptor Tyrosine Kinases Involved in Tumor Progression and Angiogenesis , 2004, Cancer Research.

[176]  J. Truebenbach,et al.  Radiopacity of current endovascular stents: evaluation in a multiple reader phantom study. , 2004, Journal of vascular and interventional radiology : JVIR.

[177]  T. Park,et al.  Comparative study on sustained release of human growth hormone from semi-crystalline poly(L-lactic acid) and amorphous poly(D,L-lactic-co-glycolic acid) microspheres: morphological effect on protein release. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[178]  L. Koole,et al.  Coils and tubes releasing heparin. Studies on a new vascular graft prototype. , 2004, Biomaterials.

[179]  O. Corrigan,et al.  Effect of poly-hydroxy aliphatic ester polymer type on amoxycillin release from cylindrical compacts. , 2003, International journal of pharmaceutics.

[180]  T. Boulikas,et al.  Cisplatin and platinum drugs at the molecular level. (Review). , 2003, Oncology reports.

[181]  Z. Siddik,et al.  Cisplatin: mode of cytotoxic action and molecular basis of resistance , 2003, Oncogene.

[182]  D. Sawyer Bioprocessing – no longer a field of dreams , 2003 .

[183]  J. Perez,et al.  Cisplatin biochemical mechanism of action: from cytotoxicity to induction of cell death through interconnections between apoptotic and necrotic pathways. , 2003, Current medicinal chemistry.

[184]  David A. Glassner,et al.  Applications of life cycle assessment to NatureWorks polylactide (PLA) production , 2003 .

[185]  J. Folkman Role of angiogenesis in tumor growth and metastasis. , 2002, Seminars in oncology.

[186]  A. Södergård,et al.  Properties of lactic acid based polymers and their correlation with composition , 2002 .

[187]  B. Desoize,et al.  Particular aspects of platinum compounds used at present in cancer treatment. , 2002, Critical reviews in oncology/hematology.

[188]  Nureddin Ashammakhi,et al.  Strength retention properties of self-reinforced poly L-lactide (SR-PLLA) sutures compared with polyglyconate (Maxon) and polydioxanone (PDS) sutures. An in vitro study. , 2002, Biomaterials.

[189]  Keigo Aoi,et al.  Stereoselective ring-opening polymerization of racemic lactide using aluminum-achiral ligand complexes: exploration of a chain-end control mechanism. , 2002, Journal of the American Chemical Society.

[190]  S. Hyon,et al.  An Experimental Study of Regional Chemotherapy Using CDDP-Loaded Microspheres for Esophageal Cancer , 2002, Surgery Today.

[191]  A. Lloyd,et al.  Interfacial bioengineering to enhance surface biocompatibility. , 2002, Medical device technology.

[192]  P. Moroz,et al.  Targeting liver tumors with hyperthermia: Ferromagnetic embolization in a rabbit liver tumor model , 2001, Journal of surgical oncology.

[193]  J. Tasto,et al.  Bioabsorbable implants in orthopaedics: new developments and clinical applications. , 2001, The Journal of the American Academy of Orthopaedic Surgeons.

[194]  L. Avérous,et al.  Poly(lactic acid): plasticization and properties of biodegradable multiphase systems , 2001 .

[195]  G. Yalcin,et al.  THE SPECTROPHOTOMETRIC DETERMINATION OF CISPLATIN IN URINE, USING o-PHENYLENEDIAMINE AS DERIVATIZING AGENT , 2001 .

[196]  L. Claes,et al.  Resorbable polymer fibers for ligament augmentation. , 2001, Journal of biomedical materials research.

[197]  P. Gruber,et al.  Polylactic Acid Technology , 2000 .

[198]  J. Vacanti,et al.  In vitro degradation of porous poly(L-lactic acid) foams. , 2000, Biomaterials.

[199]  H. Uehata,et al.  Initial and 6-month results of biodegradable poly-l-lactic acid coronary stents in humans. , 2000, Circulation.

[200]  M. Léonard,et al.  Surface modification of poly(lactic acid) nanospheres using hydrophobically modified dextrans as stabilizers in an o/w emulsion/evaporation technique. , 2000, Journal of biomedical materials research.

[201]  Y. Machida,et al.  Pharmacokinetics of prolonged-release CPT-11-loaded microspheres in rats. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[202]  Gregory L. Baker,et al.  Stereoselective polymerization of a racemic monomer with a racemic catalyst: Direct preparation of the polylactic acid stereocomplex from racemic lactide , 2000 .

[203]  Y. Ikada,et al.  Biodegradable polyesters for medical and ecological applications , 2000 .

[204]  D. Rüfenacht,et al.  Radiopaque polymeric materials for medical applications. Current aspects of biomaterial research. , 1999, Investigative radiology.

[205]  T. Park,et al.  A new preparation method for protein loaded poly(D, L-lactic-co-glycolic acid) microspheres and protein release mechanism study. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[206]  M. Al-Ahwal,et al.  Chemoembolization in hepatocellular carcinoma. , 1998, Saudi medical journal.

[207]  J. Lunt Large-scale production, properties and commercial applications of polylactic acid polymers , 1998 .

[208]  O'donnell,et al.  Preparation of microspheres by the solvent evaporation technique. , 1997, Advanced drug delivery reviews.

[209]  I. Cabasso,et al.  Radiopaque copolymers of styryldiphenylbismuth vinylbenzylphosphonate and methyl methacrylate , 1997 .

[210]  Y Ikada,et al.  Synthesis of polylactides with different molecular weights. , 1997, Biomaterials.

[211]  D. Murray,et al.  Radio-opaque agents in bone cement increase bone resorption. , 1997, The Journal of bone and joint surgery. British volume.

[212]  Stephen P. McCarthy,et al.  Effects of physical aging, crystallinity, and orientation on the enzymatic degradation of poly(lactic acid) , 1996 .

[213]  O. Böstman,et al.  Absorbable devices in the fixation of fractures. , 1996, The Journal of trauma.

[214]  S. Wallace,et al.  Percutaneous intratumoral injection of cisplatin microspheres in tumor-bearing rats to diminish acute nephrotoxicity , 1996, Anti-cancer drugs.

[215]  Catia Bastioli,et al.  Effect of molecular weight and crystallinity on poly(lactic acid) mechanical properties , 1996 .

[216]  H. Kricheldorf,et al.  Polylactides ‐ synthesis, characterization and medical application , 1996 .

[217]  C. M. Agrawal,et al.  Sterilization, toxicity, biocompatibility and clinical applications of polylactic acid/polyglycolic acid copolymers. , 1996, Biomaterials.

[218]  R. Mehta,et al.  Prediction of solvent removal profile and effect on properties for peptide-loaded PLGA microspheres prepared by solvent extraction/ evaporation method , 1995 .

[219]  M. Jonkman,et al.  Reinforced poly(L-lactic acid) fibres as suture material. , 1995, Journal of applied biomaterials : an official journal of the Society for Biomaterials.

[220]  Raymond E. Davis,et al.  Patterns in Hydrogen Bonding: Functionality and Graph Set Analysis in Crystals , 1995 .

[221]  Kazuhiko Suzuki,et al.  Basic Properties of Polylactic Acid Produced by the Direct Condensation Polymerization of Lactic Acid , 1995 .

[222]  Suming Li,et al.  Hydrolytic degradation of devices based on poly(DL-lactic acid) size-dependence. , 1995, Biomaterials.

[223]  Tae Gwan Park,et al.  Degradation of poly(d,l-lactic acid) microspheres: effect of molecular weight , 1994 .

[224]  Stephen P. McCarthy,et al.  Polylactide stereochemistry: effect on enzymic degradability , 1994 .

[225]  D. Pichora,et al.  An Investigation of Poly(lactic acid) Degradation , 1994 .

[226]  G. Dusheiko,et al.  Management of hepatocellular carcinoma. , 1992, Journal of hepatology.

[227]  M. Scandola,et al.  Thermal properties and physical ageing of poly (l-lactic acid) , 1992 .

[228]  P. Törmälä,et al.  Absorption, biocompatibility, and fixation properties of polylactic acid in bone tissue: an experimental study in rats. , 1991, Clinical orthopaedics and related research.

[229]  R. Jalil,et al.  Biodegradable poly(lactic acid) and poly(lactide-co-glycolide) microcapsules: problems associated with preparative techniques and release properties. , 1990, Journal of microencapsulation.

[230]  J. Benoit,et al.  Formation and characterization of cisplatin loaded poly(d,l-lactide) microspheres for chemoembolization. , 1986, Journal of pharmaceutical sciences.

[231]  T. Kondo,et al.  Mechanism of hydrolytic degradation of poly(L-lactide) microcapsules: effects of pH, ionic strength and buffer concentration. , 1986, Journal of microencapsulation.

[232]  D. Woodfield Hepatocellular carcinoma. , 1986, The New Zealand medical journal.

[233]  T. Mosmann Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.

[234]  H. Flack,et al.  On enantiomorph‐polarity estimation , 1983 .

[235]  G L Kimmel,et al.  Aliphatic polyesters II. The degradation of poly (DL-lactide), poly (epsilon-caprolactone), and their copolymers in vivo. , 1981, Biomaterials.

[236]  A. Schindler,et al.  Polylactide. II. Viscosity–molecular weight relationships and unperturbed chain dimensions , 1979 .

[237]  R. White,et al.  Long term follow-up of transcatheter embolization with autologous clot, oxycel and gelfoam in domestic swine. , 1977, Investigative radiology.

[238]  G. Wegner,et al.  Investigation of the structure of solution grown crystals of lactide copolymers by means of chemical reactions , 1973 .

[239]  G. H. Ayres,et al.  Spectrophotometric determination of platinum with o-phenylenediamine. , 1973, Talanta.

[240]  F Leonard,et al.  Biodegradable poly(lactic acid) polymers. , 1971, Journal of biomedical materials research.

[241]  K C Pani,et al.  Polylactic acid for surgical implants , 1966, Archives of surgery.